Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Show all lipids with this classification Show all lipids assigned to this classification.
Show only primary classification Show only those lipids which have been assigned to this class as the primary classification.
Show only secondary classifications Show only lipids which have this functionality but are not primarily assigned to this class.

Fatty Acyls [FA]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA01030826 30:4(15Z,18Z,21Z,24Z) 15Z,18Z,21Z,24Z-triacontatetraenoic acid FA 30:4 C30H52O2 444.396731
LMFA01030830 38:4(23Z,26Z,29Z,32Z) 23Z,26Z,29Z,32Z-octatriacontatetraenoic acid FA 38:4 C38H68O2 556.521931
LMFA01030831 Shibic acid 11Z,14Z,17Z,20Z,23Z-hexacosapentaenoic acid FA 26:5 C26H42O2 386.318481
LMFA01030838 26:6(8Z,11Z,14Z,17Z,20Z,23Z) 8Z,11Z,14Z,17Z,20Z,23Z-hexacosahexaenoic acid FA 26:6 C26H40O2 384.302831
LMFA01030847 30:5(12Z,15Z,18Z,21Z,24Z) 12Z,15Z,18Z,21Z,24Z-triacontapentaenoic acid FA 30:5 C30H50O2 442.381081
LMFA01030850 36:5(18Z,21Z,24Z,27Z,30Z) 18Z,21Z,24Z,27Z,30Z-hexatriacontapentaenoic acid FA 36:5 C36H62O2 526.474981
LMFA03100005 15-epi-15-iso-LGE2 (8S,12R)-10,11-seco-9,11-dioxo-15R-hydroxy-5Z,13E-prostadienoic acid FA 20:4;O3 C20H32O5 352.224976
LMFA03100005 15-epi-15-iso-LGE2 (8S,12R)-10,11-seco-9,11-dioxo-15R-hydroxy-5Z,13E-prostadienoic acid FA 20:4;O3 C20H32O5 352.224976
LMFA03100005 15-epi-15-iso-LGE2 (8S,12R)-10,11-seco-9,11-dioxo-15R-hydroxy-5Z,13E-prostadienoic acid FA 20:4;O3 C20H32O5 352.224976
LMFA03100005 15-epi-15-iso-LGE2 (8S,12R)-10,11-seco-9,11-dioxo-15R-hydroxy-5Z,13E-prostadienoic acid FA 20:4;O3 C20H32O5 352.224976
LMFA07010017 WE 13:0/16:1(9Z) Tridecyl 9Z-hexadecenoate WE 29:1 C29H56O2 436.428031
LMFA07010017 WE 13:0/16:1(9Z) Tridecyl 9Z-hexadecenoate WE 29:1 C29H56O2 436.428031
LMFA11000523 7-Pentadecene 7-Pentadecene C15H30 210.234751
LMFA01030852 delta2-THA 2E,6Z,9Z,12Z,15Z,18Z,21Z-tetracosaheptaenoic acid FA 24:7 C24H34O2 354.255881
LMFA08020105 N-docosahexaenoyl GABA N-(4Z,7Z,10Z,12E,16Z,19Z-docosahexaenoyl)-gamma-aminobutyric acid NA 26:7;O2 C26H39NO3 413.292994
LMFA08020105 N-docosahexaenoyl GABA N-(4Z,7Z,10Z,12E,16Z,19Z-docosahexaenoyl)-gamma-aminobutyric acid NA 26:7;O2 C26H39NO3 413.292994
LMFA07010029 WE 25:0/16:1(9Z) Pentacosanyl 9Z-hexadecenoate WE 41:1 C41H80O2 604.615831
LMFA07010029 WE 25:0/16:1(9Z) Pentacosanyl 9Z-hexadecenoate WE 41:1 C41H80O2 604.615831
LMFA02030054 16-epi-16-E1c-PhytoP 8-((1R,2S,3R)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)octanoic acid FA 18:3;O3 C18H30O5 326.209326
LMFA08020107 N-palmitoyl threonine N-hexadecanoyl-threonine NAThr 16L0 C20H39NO4 357.287909
LMFA08020107 N-palmitoyl threonine N-hexadecanoyl-threonine NAThr 16L0 C20H39NO4 357.287909
LMFA01030868 21:2(5Z,16Z) 5Z,16Z-heneicosadienoic acid FA 21:2 C21H38O2 322.287181
LMFA08020121 N-linoleoyl valine N-(9Z,12Z-octadecadienoyl)-valine NAVal 18:2 C23H41NO3 379.308644
LMFA08020121 N-linoleoyl valine N-(9Z,12Z-octadecadienoyl)-valine NAVal 18:2 C23H41NO3 379.308644
LMFA08020121 N-linoleoyl valine N-(9Z,12Z-octadecadienoyl)-valine NAVal 18:2 C23H41NO3 379.308644
LMFA08020122 N-stearoyl valine N-octadecanoyl-valine NAVal 18:0 C23H45NO3 383.339944
LMFA08020122 N-stearoyl valine N-octadecanoyl-valine NAVal 18:0 C23H45NO3 383.339944
LMFA08020129 N-docosahexaenoyl glutamine N-(4Z,7Z,10Z,12E,16Z,19Z-docosahexaenoyl)-glutamine NAGln 22:6 C27H40N2O4 456.298808
LMFA08020129 N-docosahexaenoyl glutamine N-(4Z,7Z,10Z,12E,16Z,19Z-docosahexaenoyl)-glutamine NAGln 22:6 C27H40N2O4 456.298808
LMFA08020129 N-docosahexaenoyl glutamine N-(4Z,7Z,10Z,12E,16Z,19Z-docosahexaenoyl)-glutamine NAGln 22:6 C27H40N2O4 456.298808
LMFA03110107 ent-PGD2 9R,15R-dihydroxy-11-oxo-5Z,13E-prostadienoic acid-cyclo[8S,12S] FA 20:4;O3 C20H32O5 352.224976
LMFA08020135 N-stearoyl histidine N-octadecanoyl-histidine NAHis 18:0 C24H43N3O3 421.330442
LMFA01030872 30:3(5Z,9Z,23Z) 5Z,9Z,23Z-triacontatrienoic acid FA 30:3 C30H54O2 446.412381
LMFA01020361 27:2(5Z,9Z)(25Me) 25-methyl-5Z,9Z-heptacosadienoic acid FA 28:2 C28H52O2 420.396731
LMFA01020361 27:2(5Z,9Z)(25Me) 25-methyl-5Z,9Z-heptacosadienoic acid FA 28:2 C28H52O2 420.396731
LMFA01020362 27:2(5Z,9Z)(26Me) 26-methyl-5Z,9Z-heptacosadienoic acid FA 28:2 C28H52O2 420.396731
LMFA01020362 27:2(5Z,9Z)(26Me) 26-methyl-5Z,9Z-heptacosadienoic acid FA 28:2 C28H52O2 420.396731
LMFA01020366 29:2(5Z,9Z)(26Me) 26-methyl-5Z,9Z-octacosadienoic acid FA 30:2 C30H56O2 448.428031
LMFA01020366 29:2(5Z,9Z)(26Me) 26-methyl-5Z,9Z-octacosadienoic acid FA 30:2 C30H56O2 448.428031
LMFA01030909 21:1(7Z) 7Z-heneicosenoic acid FA 21:1 C21H40O2 324.302831
LMFA02030023 ent-16-F1c-PhytoP 8-((1S,2R,3S,5R)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)octanoic acid FA 18:2;O3 C18H32O5 328.224976
LMFA08020234 N,N-bis(4-acetamidobutyl)-15-methylhexadec-6E-enamide N,N-bis(4-acetamidobutyl)-15-methylhexadec-6E-enamide C29H55N3O3 493.424342
LMFA08020234 N,N-bis(4-acetamidobutyl)-15-methylhexadec-6E-enamide N,N-bis(4-acetamidobutyl)-15-methylhexadec-6E-enamide C29H55N3O3 493.424342
LMFA08020234 N,N-bis(4-acetamidobutyl)-15-methylhexadec-6E-enamide N,N-bis(4-acetamidobutyl)-15-methylhexadec-6E-enamide C29H55N3O3 493.424342
LMFA07070061 Docosa-4,7,10,13,16-pentaenoyl carnitine 3-[(4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoyloxy]-4-(trimethylazaniumyl)butanoate CAR 22:5 C29H47NO4 473.350510
LMFA07070061 Docosa-4,7,10,13,16-pentaenoyl carnitine 3-[(4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoyloxy]-4-(trimethylazaniumyl)butanoate CAR 22:5 C29H47NO4 473.350510
LMFA04030004 Resolvin D6 4S,17S-dihydroxy-5E,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid FA 22:6;O2 C22H32O4 360.230061
LMFA04030004 Resolvin D6 4S,17S-dihydroxy-5E,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid FA 22:6;O2 C22H32O4 360.230061
LMFA04030004 Resolvin D6 4S,17S-dihydroxy-5E,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid FA 22:6;O2 C22H32O4 360.230061
LMFA12000022 3-Hydroxypentan-2-one 3-Hydroxypentan-2-one C5H10O2 102.068080